{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T02:10:17Z","timestamp":1773886217478,"version":"3.50.1"},"reference-count":34,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":215,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Allergy"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1111\/all.12571","type":"journal-article","created":{"date-parts":[[2015,1,8]],"date-time":"2015-01-08T14:11:57Z","timestamp":1420726317000},"page":"436-442","source":"Crossref","is-referenced-by-count":21,"title":["Oxidative stress markers are increased in patients with mastocytosis"],"prefix":"10.1111","volume":"70","author":[{"given":"S.","family":"Gangemi","sequence":"first","affiliation":[{"name":"Operative Unit of Allergy and Clinical Immunology; Department of Clinical and Experimental Medicine; University of Messina; Messina Italy"},{"name":"Institute of Clinical Physiology; IFC CNR; Messina Unit; Messina Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. L.","family":"Minciullo","sequence":"additional","affiliation":[{"name":"Operative Unit of Allergy and Clinical Immunology; Department of Clinical and Experimental Medicine; University of Messina; Messina Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Magliacane","sequence":"additional","affiliation":[{"name":"Division of Immunopathology and Respiratory Disease; Battipaglia Hospital; Salerno Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Saitta","sequence":"additional","affiliation":[{"name":"Operative Unit of Allergy and Clinical Immunology; Department of Clinical and Experimental Medicine; University of Messina; Messina Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Loffredo","sequence":"additional","affiliation":[{"name":"Department of Translational Medical Sciences and Center for Basic and Clinical Immunology Research (CISI); University of Naples Federico II; Naples Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Saija","sequence":"additional","affiliation":[{"name":"Department of Drug Sciences and Health Products; University of Messina; Messina Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Cristani","sequence":"additional","affiliation":[{"name":"Department of Drug Sciences and Health Products; University of Messina; Messina Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Marone","sequence":"additional","affiliation":[{"name":"Department of Translational Medical Sciences and Center for Basic and Clinical Immunology Research (CISI); University of Naples Federico II; Naples Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Triggiani","sequence":"additional","affiliation":[{"name":"Division of Allergy and Clinical Immunology; University of Salerno; Salerno Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2015,1,29]]},"reference":[{"key":"10.1111\/all.12571-BIB0001|all12571-cit-0001","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1365-2362.2007.01807.x","article-title":"Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria","volume":"37","author":"Valent","year":"2007","journal-title":"Eur J Clin Invest"},{"key":"10.1111\/all.12571-BIB0002|all12571-cit-0002","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0145-2126(01)00038-8","article-title":"Diagnostic criteria and classification of mastocytosis: a consensus proposal","volume":"25","author":"Valent","year":"2001","journal-title":"Leuk Res"},{"key":"10.1111\/all.12571-BIB0003|all12571-cit-0003","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0145-2126(02)00168-6","article-title":"Aggressive systemic mastocytosis and related mast cell disorders: current treatment options and proposed response criteria","volume":"27","author":"Valent","year":"2003","journal-title":"Leuk Res"},{"key":"10.1111\/all.12571-BIB0004|all12571-cit-0004","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1111\/all.12436","article-title":"Proposed diagnostic algorithm for patients with suspected mastocytosis: a proposal of the European Competence Network on Mastocytosis","volume":"69","author":"Valent","year":"2014","journal-title":"Allergy"},{"key":"10.1111\/all.12571-BIB0005|all12571-cit-0005","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000323763","article-title":"Clinical and laboratory parameters of mast cells activation as basis for the formulation of diagnostic criteria","volume":"156","author":"Valent","year":"2011","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1111\/all.12571-BIB0006|all12571-cit-0006","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2165\/11588890-000000000-00000","article-title":"Diagnosis and treatment of cutaneous mastocytosis in children: practical recommendations","volume":"12","author":"Castells","year":"2011","journal-title":"Am J Clin Dermatol"},{"key":"10.1111\/all.12571-BIB0007|all12571-cit-0007","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.iac.2013.09.001","article-title":"Mastocytosis","volume":"34","author":"Carter","year":"2014","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1111\/all.12571-BIB0008|all12571-cit-0008","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1111\/j.1365-2222.2007.02804.x","article-title":"Prevalence of allergy and anaphylactic symptoms in 210 adult and pediatric patients with mastocytosis in Spain: a study of the Spanish network on mastocytosis (REMA)","volume":"37","author":"Gonzalez de Olano","year":"2007","journal-title":"Clin Exp Allergy"},{"key":"10.1111\/all.12571-BIB0009|all12571-cit-0009","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1398-9995.2007.01569.x","article-title":"Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients","volume":"63","author":"Brockow","year":"2008","journal-title":"Allergy"},{"key":"10.1111\/all.12571-BIB0010|all12571-cit-0010","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1152\/japplphysiol.00702.2009","article-title":"Obesity, asthma, and oxidative stress","volume":"108","author":"Holguin","year":"2010","journal-title":"J Appl Physiol"},{"key":"10.1111\/all.12571-BIB0011|all12571-cit-0011","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1067\/mai.2002.126780","article-title":"Oxidative stress in allergic respiratory diseases","volume":"110","author":"Bowler","year":"2002","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.12571-BIB0012|all12571-cit-0012","first-page":"101","article-title":"Differences in the behavior of advanced glycation end products and advanced oxidation protein products in patients with allergic rhinitis","volume":"23","author":"Di Lorenzo","year":"2013","journal-title":"J Investig Allergol Clin Immunol"},{"key":"10.1111\/all.12571-BIB0013|all12571-cit-0013","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1002\/tox.21818","article-title":"Acrolein induction of oxidative stress and degranulation in mast cells","volume":"29","author":"Hochman","year":"2014","journal-title":"Environ Toxicol"},{"key":"10.1111\/all.12571-BIB0014|all12571-cit-0014","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1476-5829.2012.00343.x","article-title":"Redox status evaluation in dogs affected by mast cell tumour","volume":"12","author":"Finotello","year":"2014","journal-title":"Vet Comp Oncol"},{"key":"10.1111\/all.12571-BIB0015|all12571-cit-0015","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3109\/10715760903380466","article-title":"Compound 48\/80 causes oxidative stress in the adrenal gland of rats through mast cell degranulation","volume":"44","author":"Kaida","year":"2010","journal-title":"Free Radic Res"},{"key":"10.1111\/all.12571-BIB0016|all12571-cit-0016","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ijheh.2011.11.001","article-title":"Increased serum levels of advanced oxidation protein products and glycation end products in subjects exposed to low-dose benzene","volume":"215","author":"Spatari","year":"2012","journal-title":"Int J Hyg Environ Health"},{"key":"10.1111\/all.12571-BIB0017|all12571-cit-0017","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3109\/07357907.2011.629383","article-title":"Relationship between advanced oxidation protein products, advanced glycation end products, and S-nitrosylated proteins with biological risk and MDR-1 polymorphisms in patients affected by B-chronic lymphocytic leukemia","volume":"30","author":"Gangemi","year":"2012","journal-title":"Cancer Invest"},{"key":"10.1111\/all.12571-BIB0018|all12571-cit-0018","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.clinbiochem.2012.07.100","article-title":"Changes in advanced oxidation protein products, advanced glycation end products, and s-nitrosylated proteins, in patients affected by polycythemia vera and essential thrombocythemia","volume":"45","author":"Musolino","year":"2012","journal-title":"Clin Biochem"},{"key":"10.1111\/all.12571-BIB0019|all12571-cit-0019","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.jaci.2010.11.020","article-title":"Potential roles of pentosidine in age-related and disease-related impairment of pulmonary functions in patients with asthma","volume":"127","author":"Kanazawa","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.12571-BIB0020|all12571-cit-0020","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1007\/s00011-012-0498-7","article-title":"Increase of novel biomarkers for oxidative stress in patients with plasma cell disorders and in multiple myeloma patients with bone lesions","volume":"61","author":"Gangemi","year":"2012","journal-title":"Inflamm Res"},{"key":"10.1111\/all.12571-BIB0021|all12571-cit-0021","doi-asserted-by":"crossref","first-page":"R205","DOI":"10.1186\/ar3538","article-title":"Advanced glycation endproducts are increased in rheumatoid arthritis patients with controlled disease","volume":"13","author":"Groot","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"10.1111\/all.12571-BIB0022|all12571-cit-0022","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3109\/08820139.2010.532267","article-title":"AGE-RAGE in multiple sclerosis brain","volume":"40","author":"Sternberg","year":"2011","journal-title":"Immunol Invest"},{"key":"10.1111\/all.12571-BIB0023|all12571-cit-0023","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.rmed.2010.11.001","article-title":"Advanced glycation end products and its receptor (RAGE) are increased in patients with COPD","volume":"105","author":"Wu","year":"2010","journal-title":"Respir Med"},{"key":"10.1111\/all.12571-BIB0024|all12571-cit-0024","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1172\/JCI3042","article-title":"The myeloperoxidase system of human phagocytes generates Nepsilon-(carboxymethyl)lysine on proteins: a mechanism for producing advanced glycation end products at sites of inflammation","volume":"104","author":"Anderson","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1111\/all.12571-BIB0025|all12571-cit-0025","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.clim.2005.01.011","article-title":"IL-6 levels predict disease variant and extent of organ involvement in patients with mastocytosis","volume":"115","author":"Brockow","year":"2005","journal-title":"Clin Immunol"},{"key":"10.1111\/all.12571-BIB0026|all12571-cit-0026","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jaci.2012.11.008","article-title":"Serum IL-31 levels are increased in a subset of patients with mastocytosis and correlate with disease severity in adult patients","volume":"132","author":"Hartmann","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.12571-BIB0027|all12571-cit-0027","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1111\/j.1365-2362.2008.02047.x","article-title":"Clinical correlates of blood serotonin levels in patients with mastocytosis","volume":"38","author":"Kushnir-Sukhov","year":"2008","journal-title":"Eur J Clin Invest"},{"key":"10.1111\/all.12571-BIB0028|all12571-cit-0028","doi-asserted-by":"crossref","first-page":"3688","DOI":"10.2174\/138161207783018545","article-title":"Non enzymatic glycated proteins in the blood and cardiovascular disease","volume":"13","author":"Misciagna","year":"2007","journal-title":"Curr Pharm Des"},{"key":"10.1111\/all.12571-BIB0029|all12571-cit-0029","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1016\/j.bbamcr.2008.08.010","article-title":"Extracellular superoxide released from mitochondria mediates mast cell death by advanced glycation end products","volume":"1783","author":"Yoshimaru","year":"2008","journal-title":"Biochim Biophys Acta"},{"key":"10.1111\/all.12571-BIB0030|all12571-cit-0030","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/j.1476-5381.2010.00905.x","article-title":"Advanced glycation end products (AGEs) activate mast cells","volume":"161","author":"Sick","year":"2010","journal-title":"Br J Pharmacol"},{"key":"10.1111\/all.12571-BIB0031|all12571-cit-0031","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.bbamcr.2012.10.021","article-title":"RAGE in tissue homeostasis, repair and regeneration","volume":"1833","author":"Sorci","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1111\/all.12571-BIB0032|all12571-cit-0032","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.tvjl.2013.10.028","article-title":"Advanced oxidation protein products are generated by bovine neutrophils and inhibit free radical production in vitro","volume":"199","author":"Bordignon","year":"2014","journal-title":"Vet J"},{"key":"10.1111\/all.12571-BIB0033|all12571-cit-0033","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.freeradbiomed.2011.05.010","article-title":"Extending life span by increasing oxidative stress","volume":"51","author":"Ristow","year":"2011","journal-title":"Free Radic Biol Med"},{"key":"10.1111\/all.12571-BIB0034|all12571-cit-0034","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.urology.2003.08.010","article-title":"Protective effect of vasoactive intestinal peptide on testicular torsion-detorsion injury: association with heparin-containing mast cells","volume":"63","author":"Can","year":"2004","journal-title":"Urology"}],"container-title":["Allergy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fall.12571","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T12:43:08Z","timestamp":1717677788000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/all.12571"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,29]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"URL":"https:\/\/doi.org\/10.1111\/all.12571","relation":{},"ISSN":["0105-4538"],"issn-type":[{"value":"0105-4538","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1,29]]}}}